magnesium carbonate has been researched along with Chronic Kidney Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ai, X; Chen, X; Dong, H; Feng, J; Huang, B; Huang, X; Li, J; Li, L; Li, X; Li, Y; Luo, H; Xiao, H; Xue, G; You, S; Zhang, Y | 1 |
Adorni, MP; Biancorosso, N; Bressan, A; Brilli, E; Chen, H; Dall'Acqua, S; Faggin, E; Ferri, N; Lupo, MG; Neutel, C; Rattazzi, M; Salvalaio, M; Sut, S; Tarantino, G; Vivian, G | 1 |
Goumenos, DS; Papachristou, E; Sonikian, M | 1 |
Kotegawa, T; Koya, Y; Machi, Y; Namiki, N; Shobu, Y; Uchida, S | 1 |
2 review(s) available for magnesium carbonate and Chronic Kidney Diseases
Article | Year |
---|---|
Comparative Efficacy and Acceptability of 12 Phosphorus-Lowering Drugs in Adults with Hyperphosphatemia and Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Humans; Hyperphosphatemia; Network Meta-Analysis; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Optimal use of phosphate binders in chronic kidney disease.
Topics: Aluminum Hydroxide; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Lanthanum; Magnesium; Patient Compliance; Phosphates; Polyamines; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2013 |
2 other study(ies) available for magnesium carbonate and Chronic Kidney Diseases
Article | Year |
---|---|
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line.
Topics: Acyl Coenzyme A; Adenine; Animals; Anticholesteremic Agents; Cell Line, Tumor; Cholesterol; Cysteine; Dietary Supplements; Humans; Hypercholesterolemia; Iron; Magnesium; Male; Rats, Sprague-Dawley; Receptors, LDL; Renal Insufficiency, Chronic; Simvastatin; Uremia; Vascular Calcification | 2020 |
Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.
Topics: Administration, Oral; Adsorption; Aluminum Hydroxide; Amlodipine; Aspirin; Carbon; Drug Interactions; Glycine; Humans; Intestinal Absorption; Losartan; Magnesium; Metoprolol; Models, Biological; Nifedipine; Oxides; Renal Insufficiency, Chronic; Solubility; Triazolam | 2016 |